Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.
The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.
Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Concord Biotech IPO Details
Concord Biotech IPO is a Book Built Issue. The IPO total issue size is Rs 1,551.00 Cr. The Concord Biotech IPO price is ₹705 to ₹741 per share. The IPO will list on BSE, NSE.
| IPO Date | Aug 4, 2023 to Aug 8, 2023 |
| Listing Date | [.] |
| Face Value | ₹1 per share |
| Price | ₹705 to ₹741 per share |
| Lot Size | 20 Shares |
| Total Issue Size | 20,925,652 shares (aggregating up to ₹1,551.00 Cr) |
| Offer for Sale | 20,925,652 shares of ₹1 (aggregating up to ₹1,551.00 Cr) |
| Employee Discount | Rs 70 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 104,616,204 |
Concord Biotech IPO Reservation
| QIB Shares Offered | Not more than 50% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
Concord Biotech IPO Timetable
Concord Biotech IPO opens on Aug 4, 2023, and closes on Aug 8, 2023.
| IPO Open Date | Friday, 4 August 2023 |
| IPO Close Date | Tuesday, 8 August 2023 |
| Basis of Allotment | Friday, 11 August 2023 |
| Initiation of Refunds | Monday, 14 August 2023 |
| Credit of Shares to Demat | Thursday, 17 August 2023 |
| Listing Date | Friday, 18 August 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Aug 8, 2023 |
Concord Biotech IPO Lot Size
The minimum lot size of this Concord Biotech IPO is 20 shares required is ₹14,820.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,820 |
| Retail (Max) | 13 | 260 | ₹192,660 |
| S-HNI (Min) | 14 | 280 | ₹207,480 |
| S-HNI (Max) | 67 | 1,340 | ₹992,940 |
| B-HNI (Min) | 68 | 1,360 | ₹1,007,760 |
| Lot Size Calculator |
Company Financials
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 1,182.55 | 1,312.80 | 1,513.98 |
| Revenue | 630.75 | 736.35 | 888.48 |
| Profit After Tax | 234.89 | 174.93 | 240.08 |
| Net Worth | 999.37 | 1,103.22 | 1,290.00 |
| Reserves and Surplus | |||
| Total Borrowing | 86.35 | 60.59 | 31.24 |
Amount in ₹ Crore
Key Performance Indicator
Concord Biotech IPO Market Cap is Rs 7752.06 Cr and P/E (x) is 32.29.
| KPI | Values |
|---|---|
| P/E (x) | 32.29 |
| Market Cap (₹ Cr.) | 7752.06 |
| EPS (Rs) | 20.79 |
| RoNW | 20% |
Check Concord Biotech IPO Peer Comparison here.
Objects of the Issue
The objectives of the Offer are to:
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
- Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.
Concord Biotech IPO Review (May apply)
[Dilip Davda] The company is an Indian biopharma company with many niche products. It marked a setback in the bottom line for FY22 but posted growth in the top line for the reported three fiscals. Based on FY23 financial performance, the issue appears fully priced. This entire issue is by way of OFS and no fund is going to the company. Well-informed investors may park funds for the medium to long-term rewards. Read detail review…
Concord Biotech IPO Prospectus
Company Contact Information
Concord Biotech Limited
1482-86,
Trasad Road Dholka,
Ahmedabad – 382225
Phone: 079-6813 8700
Email: complianceofficer@concordbiotech.com
Website: http://www.concordbiotech.com/
Concord Biotech IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: concordbiotech.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html